The findings of Cong et al. demonstrated that disulfidptosis-related prognostic signature, consisting of six genes (including CD2AP), was important for ovarian cancer prognostic assessment, tumor microenvironment modulation, and drug sensitivity prediction [20]. This evidence concerns the gene CD2AP and neoplasm.